Cortexcortex

Your R&D is worth more than your balance sheet shows.

Your know-how, methods and results appear in no indicator. Cortex measures them with the ICRI, then makes them known through science communication.

Measure

The ICRI, the Invisible R&D Capital Index

Five pillars, a score out of 100 and a decision-oriented report.

Communicate

Science communication

Articles, videos, podcasts, comics, talks and workshops.

An indicative online diagnostic, no commitment, immediate result.

They trust us
CNRSInsermL'Oréal
Measure

The ICRI, the Invisible R&D Capital Index

Measure the scientific capital of your R&D, draw an action plan from it, and make it defensible before a committee, a partner or an investor.

Discover the ICRI
Communicate

Science communication

Making your work clear and shareable: articles, infographics, comics, videos, talks and books.

See our formats

Three losses that the usual indicators do not show.

A laboratory's value is not limited to what it publishes or patents. Most of it remains invisible, and is lost in silence. This is what we call invisible scientific capital.

01

Tacit knowledge

Methods, practical know-how and intuitions that are written down nowhere and live only in people's heads.

02

Researchers leaving

When a researcher leaves, years of expertise leave the organisation without any usable trace.

03

Hidden value

Results judged negative or leads set aside that were worth their weight in gold, when reread at the right moment.

Handwritten laboratory notebook Empty workstation Archived records

We measure what your R&D really holds, across five pillars.

The Invisible R&D Capital Index (ICRI) is based on 26 factual indicators, entered in an online questionnaire that you complete at your own pace, with automatic saving. It produces an overall score out of 100, five sub-scores and a personalised, decision-oriented interpretation.

20%
Scientific human capital

R&D full-time equivalents, training, mentoring, three-year retention, coverage of critical skills.

25%
Technological capital and know-how

Prototypes and proofs of concept, technology readiness, reproducibility, documented procedures, FAIR data, patents.

25%
Relational capital and reputation

Active partnerships, publications and presentations, conferences and awards, attractiveness to talent, visibility among opinion leaders.

15%
Opportunity capital

Identified dormant assets, valorisation options, potential value, external funding, opportunities within eighteen months.

15%
Societal and environmental capital

Non-market benefits, control of scientific and technical risks, alignment with the Sustainable Development Goals.

Scientific human Technologicaland know-how Relationaland reputation Opportunity Societalenvironmental
51 / 100Capital under construction
Four sample readings based on fictitious cases. For each profile, five sub-scores out of 5, an overall score, a level and action priorities.

Why measure what nobody measures.

An R&D department knows what it spends and what it publishes. It rarely knows what it holds, what it risks losing, and what it could already valorise. Four situations, and what the ICRI changes in each.

Repeating the ICRI a year later shows exactly what has improved.

Take the diagnostic

Where your R&D stands, in six questions.

A first, immediate insight into what your organisation does not yet measure. Two minutes, no commitment, results on screen.

  • An indicative score out of 100
  • One question per ICRI pillar, plus one on your critical skills
  • Your result on screen and by email, with a link to book a meeting

Carried out with our team, the full ICRI then reads your capital across 26 factual indicators.

A proven method, with scientific backing.

Our work draws on a network of PhDs and on verifiable references.

Laboratoire de Météorologie DynamiqueICRI Strategic carried out in 2026

A public research laboratory of École polytechnique, Institut Polytechnique de Paris.

URIT and Pegmatiss BiotechICRI carried out in 2026

A research laboratory and its start-up: the ICRI read at the boundary between public research and business.

CNRSScientific backing

Our approach draws on leading scientists and a network of expert PhDs.

A bookPublished by EDP Sciences

Vulgariser, c'est transformer (To popularise is to transform): our editorial expertise, recognised and published.

See the book →

What our clients say.

Laboratories, universities and companies, in their own words.

Making the work of research teams visible, measurable and valuable.

Founded in 2022, Cortex also publishes the science communication media Cortex_sciences. It is led by a molecular biologist and draws on a network of around thirty scientific contributors.

What we do: make the scientific capital of R&D organisations visible, measurable and valuable.

Tatiana Kačan
President

Two master's degrees in biology, author and freelance journalist. She chairs the company Cortex and the Cortex_sciences media, and leads the consultancy's editorial vision.

Our supporters
La French Tech Paris-SaclayLa French Tech Grand ParisFrance InnovationLes Premières Île-de-FranceLes entreprises s'engagentEurobiomedÎSÉE, Île-de-France Santé EnvironnementAIPU FranceDepartment of Biotechnology, RijekaGalileo's VoyageOlivier RocaOcto Poulpe-Fiction

Invisible scientific capital, explained.

What is invisible scientific capital?

Invisible scientific capital is the share of an R&D organisation's value that is neither measured nor documented: tacit knowledge, unwritten methods, research intuitions, results set aside. It is often lost when people change jobs or leave.

How do you measure an organisation's scientific capital?

With the ICRI, the Invisible R&D Capital Index: 26 factual indicators, entered in an online questionnaire that you complete at your own pace, spread across five weighted pillars: scientific human capital (20%), technological capital and know-how (25%), relational capital and reputation (25%), opportunity capital (15%), societal and environmental capital (15%).

What is the score used for once you have it?

Three things: deciding where to focus research effort on the basis of measured elements; supporting a funding application, an evaluation or a due diligence with a dated and sourced assessment; giving non-scientific stakeholders a shared basis for discussion, whether an executive committee, a supervisory body, a partner or an investor. Carried out after the actions have been implemented, a second ICRI measures what has improved.

Who is the Cortex diagnostic for?

Companies with R&D activities and public research organisations (laboratories, research units, universities, institutes) that want to make their scientific capital visible, measurable and valuable to their peers, partners, funders and investors.

What do you receive at the end of an ICRI?

With the ICRI Essential: an overall score out of 100, a sub-score out of 5 for each pillar, a reading of each pillar, recommendations and the expected gains. The ICRI Strategic adds the cross-pillar analysis, the interactive map of your research environment, costed scenarios and a roadmap at 6, 18 and 36 months. In both cases, the report can be presented to management, a supervisory body or an executive committee, as well as to partners, funders or investors.

How does Cortex differ from a financial valuation firm?

Cortex does not carry out accounting or financial valuations of assets. We measure and valorise scientific capital in the broad sense, including its invisible part, to make it readable and actionable.